Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2907242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Laura Cheney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Hauptthemen laut MEDLINE: Autophagy, Drug Repositioning, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH grants, NIAID NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Autophagy is an evolutionarily conserved process in which intracellular macromolecules are degraded in a lysosomal-dependent manner. It is central to cellular energy homeostasis and to quality control of intracellular components. A decline in autophagic activity is associated with aging, and contributes to the development of various age-associated pathologies, including cancer. There is an ongoing need to develop chemotherapeutic agents to improve morbidity and mortality for those diagnosed with cancer, as well as to decrease the cost of cancer care. Autophagic programs are altered in cancer cells to support survival in genetically and metabolically unstable environments, making autophagy an attractive target for new chemotherapy. Antiretroviral drugs, which have dramatically increased the life- and health spans of people with human immunodeficiency virus (HIV) (PWH), have offered promise in the treatment of cancer. One mechanism underlying the antineoplastic effects of antiretroviral drugs is the alteration of cancer cell autophagy that can potentiate cell death. Antiretroviral drugs could be repurposed into the cancer chemotherapy arsenal. A more complete understanding of the impact of antiretroviral drugs on autophagy is essential for effective repurposing. This review summarizes our knowledge of the effects of antiretroviral drugs on autophagy as potential adjunctive chemotherapeutic agents, and highlights gaps to be addressed to reposition antiretroviral drugs into the antineoplastic arsenal successfully.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Förderung
- NIH grants
- NIAID NIH HHS
- NIDA NIH HHS
- NIMH NIH HHS
Zitieren
APA
Cheney, L., Barbaro, J. M., McDermott, G., & Berman, J. W. (2024). Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907242
Vancouver
Cheney L, Barbaro JM, McDermott G, Berman JW. Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907242
BibTeX
@article{Cheney2024,
author = {Cheney, Laura and Barbaro, John M and McDermott, Grace and Berman, Joan W},
title = {Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2907242}
}
EUVIMED